110 related articles for article (PubMed ID: 8101082)
21. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the bronchodilating effects of SCH 1000 with isoproterenol in patients with bronchial asthma.
Vlagopoulos T; Townley RG; Ghazanshahi S; Bewtra A; Burke K
Ann Allergy; 1976 Apr; 36(4):223-30. PubMed ID: 131499
[TBL] [Abstract][Full Text] [Related]
23. [Exercise test in the asthmatic patient. Study of 75 patients].
Orehek J; Saraga E; Gayrard P; Grimaud C; Charpin J
Nouv Presse Med; 1975 Nov; 4(39):2789-92. PubMed ID: 656
[TBL] [Abstract][Full Text] [Related]
24. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
Rampulla C; Corsico R; Majani U; Lodola E
Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
[TBL] [Abstract][Full Text] [Related]
25. [An analysis of the atrovent bronchodilator tests in bronchial asthma patients].
Vŭlcheva T
Vutr Boles; 1990; 29(4):92-5. PubMed ID: 2149229
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
Corrias A; Corona GB; Pelosi U; Corda R
Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma.
Cazzola M; Noschese P; D'Amato M; D'Amato G
Chest; 2000 Nov; 118(5):1322-6. PubMed ID: 11083681
[TBL] [Abstract][Full Text] [Related]
28. Acute ventilatory and gas-exchange effects of a new beta-2 agonist, broxaterol, in asthmatics.
Tantucci C; Burni B; Dottorini ML; Malerba M; Peccini F; Gurrieri G; Sorbini CA; Grassi V
Int J Clin Pharmacol Res; 1990; 10(3):183-9. PubMed ID: 1977709
[TBL] [Abstract][Full Text] [Related]
29. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Respir Dis; 1981 Dec; 62(6):396-404. PubMed ID: 6751838
[TBL] [Abstract][Full Text] [Related]
30. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin nasal spray in patients with chronic asthma: a double-blind crossover study vs placebo.
Dal Negro R; Turco P; Pomari C; Trevisan F
Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):144-6. PubMed ID: 2071263
[TBL] [Abstract][Full Text] [Related]
32. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children.
Rhoades RB; Leifer KN; Bloom FL; Wittig HJ
Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174
[TBL] [Abstract][Full Text] [Related]
33. A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effect.
Lunell E; Svedmyr N; Andersson KE; Persson CG
Eur J Respir Dis; 1983 Jul; 64(5):333-9. PubMed ID: 6309542
[TBL] [Abstract][Full Text] [Related]
34. Selectivity of beta-adrenoceptor agonists and antagonists in asthmatics.
Löfdahl CG
Eur J Respir Dis Suppl; 1982; 120():1-53. PubMed ID: 6125404
[No Abstract] [Full Text] [Related]
35. Carbuterol: a double-blind clinical trial comparing carbuterol and salbutamol.
Cockcroft DW; Donevan RE; Copland GM
Curr Ther Res Clin Exp; 1976 Feb; 19(2):170-9. PubMed ID: 813954
[No Abstract] [Full Text] [Related]
36. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
[TBL] [Abstract][Full Text] [Related]
37. Preliminary study on the effect of broxaterol on bronchial hyperresponsiveness in asthmatic children: influence of allergen exposure.
Benedetti M; Spezia E; Comis A; Marcer G; Boner AL
Respiration; 1993; 60(6):319-24. PubMed ID: 7904767
[TBL] [Abstract][Full Text] [Related]
38. [The bronchodilating effect of pirenzepine].
Shioya T; Kagaya M; Onodera A; Miura S; Miura K; Miura M
Arerugi; 1991 Oct; 40(10):1334-8. PubMed ID: 1772355
[TBL] [Abstract][Full Text] [Related]
39. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
Ulmer WT; Scholz HJ; Baines A
Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
[TBL] [Abstract][Full Text] [Related]
40. Bronchodilatory effect of trapidil in man.
Ikeda H; Takahashi K; Sato S; Sasaki H; Ito E; Yasui S
Arzneimittelforschung; 1984; 34(3):309-13. PubMed ID: 6539612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
